Home

Neuland Laboratories Ltd PE Ratio

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

PE

64.6

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Neuland Laboratories Ltd is 64.6 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 27 on March 2024 . This represents a CAGR of 3.71% over 5 years.
  • The Latest Trading Price of Neuland Laboratories Ltd is ₹ 13400 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Neuland Laboratories Ltd

No data available

Company Fundamentals for Neuland Laboratories Ltd

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Share Price

₹ 13400

110.95 (0.83%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Neuland Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202513289.05
13 Jan 202513092.35
10 Jan 202514025.25
09 Jan 202514621.05
08 Jan 202514910.2
07 Jan 202514288.85
06 Jan 202513653.3
03 Jan 202513788.95
02 Jan 202514292.75
01 Jan 202514308.85

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Neuland Laboratories Ltd

Asset Value vs Market Value of Neuland Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Neuland Laboratories Ltd17049
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Neuland Laboratories Ltd Explained

``

17049

Market cap

279

Earnings

64.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Neuland Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Neuland Laboratories Ltd

No data available

* All values are in %

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Neuland Laboratories Ltd News Hub

Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter

Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June 2024 as a

Read more

2024-08-01 00:00:00

Neuland Laboratories to declare Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2024

Read more

2024-10-18 00:00:00

Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter

Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended September

Read more

2024-11-06 00:00:00

Neuland Laboratories Ltd leads losers in 'A' group

Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and Triveni E

Read more

2024-11-06 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Neuland Laboratories Ltd

What is the current PE Ratio of Neuland Laboratories Ltd?

The Current PE Ratio of Neuland Laboratories Ltd is 64.55 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Neuland Laboratories Ltd last year?

The PE Ratio of Neuland Laboratories Ltd was 14.2 last year, now the PE ratio is 64.55, showing a year-on-year growth of 354.6%.

What does the PE Ratio of Neuland Laboratories Ltd indicate about its stock?

The PE Ratio of Neuland Laboratories Ltd is 64.55. This ratio indicates that investors are willing to pay 64.55 times the earnings per share for each share of Neuland Laboratories Ltd.

What is the PE Ratio Growth of Neuland Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Neuland Laboratories Ltd grew by 354.6% whereas, the EPS ratio grew by -66.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions